Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aker BioMarine Director's Dealing 2020

Aug 17, 2020

3527_dirs_2020-08-17_600dcfc8-00c6-403e-96b4-a47118e2f2a7.html

Director's Dealing

Open in viewer

Opens in your device viewer

AKBM: MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER

AKBM: MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER

August 17, 2020 – Sigve Nordrum, EVP Animal Health and Nutrition, purchased 1000 shares in Aker BioMarine AS at a price of NOK 95.86 per share on August 14 2020. The shares were acquired on Merkur Market. Following the transaction, Nordrum holds a total of 1000 shares in Aker BioMarine AS.

For further information, please contact:

Katrine Klaveness, CFO

Phone: +47 991 58 915

About Aker BioMarine: Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company, developing krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company’s fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and all the way to customers around the world. The company is dedicated to improving human and planetary health.